Wednesday, March 26, 2025
Home All News Stand Down. Page 5

Stand Down.

    We get paid to be suspicious when we’ve got nothing to be suspicious about.

    Latest

    Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...

    Stand Down. Editor / Curator -
    We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...

    Stand Down III: Guess Who This Beautiful Chart Belongs to?

    Stand Down. Editor / Curator -
    Answer Below.. $14 to $593. That's $140,000 to $5,930,000. That's Real Money.
    internet stock review

    Stand Down II: Will a Collapse in the Stock Market Spark a Run in...

    Stand Down. Editor / Curator -
    Another way to word it is "wouldn't it be nice to be making money, maybe big money - when everyone else is...
    Internet Stock Review

    Stand Down: Does Uber’s Valuation Make Sense?

    Stand Down. Editor / Curator -
    Uber's IPO Valuation Makes No Sense (Forbes). The most anticipated IPO in years is almost here....
    1...345Page 5 of 5

    Latest article

    Zomedica (ZOMDF) Surges 40% Higher, Friday.

    Uncategorized Editor / Curator -
    Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

    And We Have a Trading Idea!

    2025 Watch List Editor / Curator -
    Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

    We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

    2025 Watch List Editor / Curator -
    GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.